# Hester Biosciences

Poultry and large animal vaccines — Live attenuated, recombinant.

Source: https://en.bioecon.ru/companies/hester-biosciences/
Updated: 2026-06-25

- Country: India

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Capacity | 6.25 billion doses per annum in India (as of March 31, 2024), with an expansion project to ~13.90 billion doses expected to commercialize by June 2025 | https://www.careratings.com/upload/CompanyFiles/PR/202412121235_Hester_Biosciences_Limited.pdf |
| Certification | WHO-GMP, GLP, ISO 9001, ISO 14001, and OHSAS 18001 certified | https://cdn.prod.website-files.com/628b3c79136f616e4ba82ff6/62a0d8694f492498620dee29_2016-17.pdf |
| Regulatory approval | DSIR-approved R&D unit; previously obtained regulatory approval for BSL-3 facility | https://bsmedia.business-standard.com/_media/bs/data/announcements/bse/26072024/0cda3171-ca19-4c9c-b310-1ce8047a0ba0.pdf, https://cdn.prod.website-files.com/628b3c79136f616e4ba82ff6/62a0d8694f492498620dee29_2016-17.pdf, https://www.hester.in/about |
| Production site | Kadi (Gujarat, India), Nepal, and Tanzania | https://valueortrap.substack.com/p/hester-biosciences-ltd, https://www.careratings.com/upload/CompanyFiles/PR/202412121235_Hester_Biosciences_Limited.pdf |
| Revenue | INR 772.44 million (consolidated, Q1 FY27) | https://investoomarket.com/news/hester-biosciences-reports-q1-fy27-results-consolidated-profit-jumps-following-loan-amendment-gain.46982/ |

Independent sources: bsmedia.business-standard.com, careratings.com, cdn.prod.website-files.com, investoomarket.com, valueortrap.substack.com

## Technologies

- [Veterinary biotech & mRNA veterinary drugs](https://en.bioecon.ru/technology/veterinary-biotech-mrna-drugs/)